ABATE KRISTIN (Chief Accounting Officer) sold 0.2% of their position (53.00 shares) of KARYOPHARM THERAPEUTICS INC. on the open market
Open‑market sale worth $503.50 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/15/2026ACC: 0001193125-26-226616
Officer· Chief Accounting Officer
Since Mar 2026
+68.00
Net shares
Net buyer
$503.50
Total sold
1
Open market trades
0B · 1S
2
Total transactions
121.00 acquired · 53.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+121.00
Price / share
—
Trade value
—
% of position
0.5%
5/13/2026
23.73K→23.85K
Common Stock
Direct
Shares
−53.00
Price / share
$9.50
Trade value
$503.50
% of position
0.2%
5/14/2026
23.85K→23.80K
Total
Net shares
+68.00
Net value
-$503.50
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/13/2026 | A · Award | +121.00 | — | — | 0.5% | 23.73K | 23.85K |
| Common Stock Direct | 5/14/2026 | S · Sale | −53.00 | $9.50 | $503.50 | 0.2% | 23.85K | 23.80K |
| Total | +68.00 | -$503.50 | ||||||
Derivative Transactions0
No derivative transactions reported